Somatic retrotransposition alters the genetic landscape of the human brain. Nature

Division of Genetics and Genomics, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Edinburgh EH25 9RG, UK.
Nature (Impact Factor: 42.35). 11/2011; 479(7374):534-7. DOI: 10.1038/nature10531
Source: PubMed

ABSTRACT Retrotransposons are mobile genetic elements that use a germline 'copy-and-paste' mechanism to spread throughout metazoan genomes. At least 50 per cent of the human genome is derived from retrotransposons, with three active families (L1, Alu and SVA) associated with insertional mutagenesis and disease. Epigenetic and post-transcriptional suppression block retrotransposition in somatic cells, excluding early embryo development and some malignancies. Recent reports of L1 expression and copy number variation in the human brain suggest that L1 mobilization may also occur during later development. However, the corresponding integration sites have not been mapped. Here we apply a high-throughput method to identify numerous L1, Alu and SVA germline mutations, as well as 7,743 putative somatic L1 insertions, in the hippocampus and caudate nucleus of three individuals. Surprisingly, we also found 13,692 somatic Alu insertions and 1,350 SVA insertions. Our results demonstrate that retrotransposons mobilize to protein-coding genes differentially expressed and active in the brain. Thus, somatic genome mosaicism driven by retrotransposition may reshape the genetic circuitry that underpins normal and abnormal neurobiological processes.

Download full-text


Available from: Piero Carninci, Aug 17, 2015
1 Follower
  • Source
    • "The neuropsychiatric-related research on LINEs has mainly focused on the identification of active retrotranspositions in early and later brain development, potentially revealing signatures of expression . In their high-throughput study of somatic retrotransposition of the brain, Baillie and colleagues found that protein-coding loci are disproportionally affected by TEs, with over-representation of L1s in introns and Alus in exons [Baillie et al., 2011]. In particular, somatic L1 insertions affected genes detected in neuroblastoma and glioma (i.e., CAMTA1), dopamine receptors (DRD3), and several neurotransmitter transporters such as SLC6A5, -A6 and -A9. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transposable Elements (TEs) or transposons are low-complexity elements (e.g., LINEs, SINEs, SVAs, and HERVs) that make up to two-thirds of the human genome. There is mounting evidence that TEs play an essential role in genomic architecture and regulation related to both normal function and disease states. Recently, the identification of active TEs in several different human brain regions suggests that TEs play a role in normal brain development and adult physiology and quite possibly in psychiatric disorders. TEs have been implicated in hemophilia, neurofibromatosis, and cancer. With the advent of next-generation whole-genome sequencing approaches, our understanding of the relationship between TEs and psychiatric disorders will greatly improve. We will review the biology of TEs and early evidence for TE involvement in psychiatric disorders. © 2014 Wiley Periodicals, Inc.
    American Journal of Medical Genetics Part B Neuropsychiatric Genetics 04/2014; 165(3). DOI:10.1002/ajmg.b.32225 · 3.27 Impact Factor
    • "In addition , a recent report finds regulation of L1 retro - transposons differentially occurring in the hippocampus and caudate nucleus of human brain donors ( Baillie et al . , 2011 ) . Collectively , these findings suggest that epigenetic modifications , including methylation of histones , can regulate both euchromatin and genetic elements long thought to be ' junk DNA ' . This could broaden the range of possible cognitive and behavioral phenotypes resulting from one genome ( Singer et al . , 2010 ) ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Histone lysine methylation is a well-established transcriptional mechanism for the regulation of gene expression changes in eukaryotic cells and is now believed to function in neurons of the central nervous system to mediate the process of memory formation and behavior. In mature neurons, methylation of histone proteins can serve to both activate and repress gene transcription. This is in stark contrast to other epigenetic modifications, including histone acetylation and DNA methylation, which have largely been associated with one transcriptional state in the brain. In this review, we discuss the evidence for histone methylation mechanisms in the coordination of complex cognitive processes such as long-term memory formation and storage. In addition, we address the current literature highlighting the role of histone methylation in intellectual disability, addiction, schizophrenia, autism, depression, and neurodegeneration. Further, we discuss histone methylation within the context of other epigenetic modifications and the potential advantages of exploring this newly identified mechanism of cognition, emphasizing the possibility that this molecular process may provide an alternative locus for intervention in long-term psychopathologies that cannot be clearly linked to genes or environment alone.
    Reviews in the neurosciences 05/2013; 24(4):1-13. DOI:10.1515/revneuro-2013-0008 · 3.31 Impact Factor
  • Source
    • "That is, one assumes that a subset of the genome is evolving neutrally and is therefore indicative of the rate of unconstrained divergence, then finds that most of the rest of the genome is behaving similarly, which is therefore concluded to also be non-functional. If the first assumption is incorrect, and increasing evidence suggests that it may be (Oldmeadow et al. 2010; Faulkner et al. 2009; Baillie et al. 2011) (although this is disputed in Graur et al. 2013), the derived conclusion of nonfunctionality of the rest of the genome is also incorrect (Pheasant and Mattick 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recently articles have been published disputing the main finding of the ENCODE project that the majority of the human genome exhibits biochemical indices of function, based primarily on low sequence conservation and the existence of larger genomes in some ostensibly simpler organisms (the C-value enigma), indicating the likely presence of significant amounts of junk. Here we challenge these arguments, showing that conservation is a relative measure based on circular assumptions of the non-functionality of transposon-derived sequences and uncertain comparison sets, and that regulatory sequence evolution is subject to different and much more plastic structure-function constraints than protein-coding sequences, as well as positive selection for adaptive radiation. We also show that polyploidy accounts for the higher than expected genome sizes in some eukaryotes, compounded by variable levels of repetitive sequences of unknown significance. We argue that the extent of precise dynamic and differential cell- and tissue-specific transcription and splicing observed from the majority of the human genome is a more reliable indicator of genetic function than conservation, although the unexpectedly large amount of regulatory RNA presents a conceptual challenge to the traditional protein-centric view of human genetic programming. Finally, we suggest that resistance to these findings is further motivated in some quarters by the use of the dubious concept of junk DNA as evidence against intelligent design.
    HUGO Journal 01/2013; 7(1). DOI:10.1186/1877-6566-7-2
Show more